The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
An overview of functional nanoparticles as novel emerging antiviral therapeutic agents
Open accessAbstract
Research on highly effective antiviral drugs is essential for preventing the spread of infections and reducing losses. Recently, many functional nanoparticles have been shown to possess remarkable antiviral ability, such as quantum dots, gold and silver nanoparticles, nanoclusters, carbon dots, graphene oxide, silicon materials, polymers and dendrimers. Despite their difference in antiviral mechanism and inhibition efficacy, these functional nanoparticles-based structures have unique features as potential antiviral candidates. In this topical review, we highlight the antiviral efficacy and mechanism of these nanoparticles. Specifically, we introduce various methods for analyzing the viricidal activity of functional nanoparticles and the latest advances in antiviral functional nanoparticles. Furthermore, we systematically describe the advantages and disadvantages of these functional nanoparticles in viricidal applications. Finally, we discuss the challenges and prospects of antiviral nanostructures. This topic review covers 132 papers and will enrich our knowledge about the antiviral efficacy and mechanism of various functional nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Nanostructures in Biodiagnostics
Rosi, N. L., & Mirkin, C. A. (2005) · Chemical Reviews · doi:10.1021/cr030067f · Cited by 4,603
Mode of antiviral action of silver nanoparticles against HIV-1
Lara, H. H., Ayala-Nuñez, N. V., Ixtepan-Turrent, L., & Rodriguez-Padilla, C. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-1 · Cited by 1,061
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884
Functional Gold Nanoparticles as Potent Antimicrobial Agents against Multi-Drug-Resistant Bacteria
Li, X., Robinson, S. M., Gupta, A., Saha, K., Jiang, Z., Moyano, D. F., Sahar, A., Riley, M. A., & Rotello, V. M. (2014) · ACS Nano · doi:10.1021/nn5042625 · Cited by 765
Antimicrobial Gold Nanoclusters
Zheng, K., Setyawati, M. I., Leong, D. T., & Xie, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b02035 · Cited by 615
Therapeutic Potential of Spirooxindoles as Antiviral Agents
Ye, N., Chen, H., Wold, E. A., Shi, P.-Y., & Zhou, J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00041 · Cited by 493
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
Cagno, V., Andreozzi, P., D’Alicarnasso, M., Jacob Silva, P., Mueller, M., Galloux, M., Le Goffic, R., Jones, S. T., Vallino, M., Hodek, J., et al. (2018) · Nature Materials · doi:10.1038/nmat5053 · Cited by 428
Ghaffari, H., Tavakoli, A., Moradi, A., Tabarraei, A., Bokharaei-Salim, F., Zahmatkeshan, M., Farahmand, M., Javanmard, D., Kiani, S. J., Esghaei, M., et al. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0563-4 · Cited by 392
Inhibition of HIV Fusion with Multivalent Gold Nanoparticles
Bowman, M.-C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., & Melander, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710321g · Cited by 371
Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus
Łoczechin, A., Séron, K., Barras, A., Giovanelli, E., Belouzard, S., Chen, Y.-T., Metzler-Nolte, N., Boukherroub, R., Dubuisson, J., & Szunerits, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15032 · Cited by 320
Inhibition of Influenza Virus Infection by Multivalent Sialic‐Acid‐Functionalized Gold Nanoparticles
Papp, I., Sieben, C., Ludwig, K., Roskamp, M., Böttcher, C., Schlecht, S., Herrmann, A., & Haag, R. (2010) · Small · doi:10.1002/smll.201001349 · Cited by 313
Glycyrrhizic‐Acid‐Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms
Tong, T., Hu, H., Zhou, J., Deng, S., Zhang, X., Tang, W., Fang, L., Xiao, S., & Liang, J. (2020) · Small · doi:10.1002/smll.201906206 · Cited by 249
Self-citationA review on viral biosensors to detect human pathogens
Caygill, R. L., Blair, G. E., & Millner, P. A. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.09.038 · Cited by 230
Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin
Ting, D., Dong, N., Fang, L., Lu, J., Bi, J., Xiao, S., & Han, H. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00779 · Cited by 224
Chemistry and Structure of Graphene Oxide via Direct Imaging
Dave, S. H., Gong, C., Robertson, A. W., Warner, J. H., & Grossman, J. C. (2016) · ACS Nano · doi:10.1021/acsnano.6b02391 · Cited by 216
Biomedical Applications of Graphene Nanomaterials and Beyond
Ghosal, K., & Sarkar, K. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00376 · Cited by 211
Nanoparticulate Delivery Systems for Antiviral Drugs
Lembo, D., & Cavalli, R. (2010) · Antiviral Chemistry and Chemotherapy · doi:10.3851/imp1684 · Cited by 203
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
Chaudhuri, S., Symons, J. A., & Deval, J. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.05.005 · Cited by 203
Viral Aggregation: Impact on Virus Behavior in the Environment
Gerba, C. P., & Betancourt, W. Q. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.6b05835 · Cited by 191
Yang, X. X., Li, C. M., Li, Y. F., Wang, J., & Huang, C. Z. (2017) · Nanoscale · doi:10.1039/c7nr06520e · Cited by 187
Lin, C., Chang, L., Chu, H., Lin, H., Chang, P., Wang, R. Y. L., Unnikrishnan, B., Mao, J., Chen, S., & Huang, C. (2019) · Small · doi:10.1002/smll.201902641 · Cited by 183
Lee, M.-Y., Yang, J.-A., Jung, H. S., Beack, S., Choi, J. E., Hur, W., Koo, H., Kim, K., Yoon, S. K., & Hahn, S. K. (2012) · ACS Nano · doi:10.1021/nn302538y · Cited by 175
Lembo, D., Donalisio, M., Civra, A., Argenziano, M., & Cavalli, R. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1360863 · Cited by 174
Herpes Simplex Virus Type-1 Attachment Inhibition by Functionalized Graphene Oxide
Sametband, M., Kalt, I., Gedanken, A., & Sarid, R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am405040z · Cited by 170
Biochemistry and Medicinal Chemistry of the Dengue Virus Protease
Nitsche, C., Holloway, S., Schirmeister, T., & Klein, C. D. (2014) · Chemical Reviews · doi:10.1021/cr500233q · Cited by 158
Graphene Quantum Dots Based Systems As HIV Inhibitors
Iannazzo, D., Pistone, A., Ferro, S., Luca, L. D., Monforte, A., Romeo, R., Buemi, M. R., & Pannecouque, C. C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00448 · Cited by 151
Sreekanth, T. V. M., Nagajyothi, P. C., Muthuraman, P., Enkhtaivan, G., Vattikuti, S. V. P., Tettey, C. O., Kim, D. H., Shim, J., & Yoo, K. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.08.013 · Cited by 151
Carbon dots as inhibitors of virus by activation of type I interferon response
Du, T., Liang, J., Dong, N., Liu, L., Fang, L., Xiao, S., & Han, H. (2016) · Carbon · doi:10.1016/j.carbon.2016.09.032 · Cited by 149
Self-citationSong, Z., Wang, X., Zhu, G., Nian, Q.-G., Zhou, H., Yang, D. L., Qin, C., & Tang, R. (2014) · Small · doi:10.1002/smll.201401706 · Cited by 148
Daaboul, G. G., Yurt, A., Zhang, X., Hwang, G. M., Goldberg, B. B., & Ünlü, M. S. (2010) · Nano Letters · doi:10.1021/nl103210p · Cited by 145
Catalytic inactivation of influenza virus by iron oxide nanozyme
Qin, T., Ma, R., Yin, Y., Miao, X., Chen, S., Fan, K., Xi, J., Liu, Q., Gu, Y., Yin, Y., et al. (2019) · Theranostics · doi:10.7150/thno.35826 · Cited by 140
Ultra-stable and Biofunctionalizable Gold Nanoparticles
Gupta, A., Moyano, D. F., Parnsubsakul, A., Papadopoulos, A., Wang, L.-S., Landis, R. F., Das, R., & Rotello, V. (2016) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.6b02548 · Cited by 139
Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity
Huang, S., Gu, J. J., Ye, J., Fang, B., Wan, S., Wang, C., Ashraf, U., Li, Q., Wang, X., Shao, L., et al. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.02.010 · Cited by 138
Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective
Clercq, E. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900932g · Cited by 137
Multivalent Flexible Nanogels Exhibit Broad-Spectrum Antiviral Activity by Blocking Virus Entry
Dey, P., Bergmann, T., Cuellar‐Camacho, J. L., Ehrmann, S., Chowdhury, M. S., Zhang, M., Dahmani, I., Haag, R., & Azab, W. (2018) · ACS Nano · doi:10.1021/acsnano.8b01616 · Cited by 136
Organotin polymers as anticancer and antiviral agents
Carraher, C. E., & Roner, M. R. (2013) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2013.05.033 · Cited by 130
Fluorine Functionalized Graphene Quantum Dots as Inhibitor against hIAPP Amyloid Aggregation
Yousaf, M., Huang, H., Li, P., Wang, C., & Yang, Y. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00015 · Cited by 124
LaBauve, A. E., Rinker, T. E., Noureddine, A., Serda, R. E., Howe, J. Y., Sherman, M. B., Rasley, A., Brinker, C. J., Sasaki, D. Y., & Negrete, O. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32033-w · Cited by 114
Angioletti‐Uberti, S. (2017) · npj Computational Materials · doi:10.1038/s41524-017-0050-y · Cited by 111
Persistence of Ebola Virus in Sterilized Wastewater
Bibby, K. J., Fischer, R. J., Casson, L. W., Stachler, E. N., Haas, C. N., & Munster, V. J. (2015) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.5b00193 · Cited by 102
Biosynthesis of Gold Nanoparticles Using Ocimum sanctum Extracts by Solvents with Different Polarity
Lee, S. Y., Krishnamurthy, S., Cho, C.-W., et al. (2016) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.6b00161 · Cited by 102
Viral Inhibition Mechanism Mediated by Surface-Modified Silica Nanoparticles
Silva, J. M. D. S. E., Melo‐Hanchuk, T. D., Santos, M. I., Kobarg, J., Bajgelman, M. C., & Cardoso, M. B. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03342 · Cited by 100
Virus inhibition induced by polyvalent nanoparticles of different sizes
Vonnemann, J., Sieben, C., Wolff, C., Ludwig, K., Böttcher, C., Herrmann, A., & Haag, R. (2013) · Nanoscale · doi:10.1039/c3nr04449a · Cited by 99
Manipulation of in Vitro Angiogenesis Using Peptide-Coated Gold Nanoparticles
Bartczak, D., Muskens, O. L., Sánchez-Elsner, T., et al. (2013) · ACS Nano · doi:10.1021/nn402111z · Cited by 98
Antioxidative and antiinflammatory activities of quercetin-loaded silica nanoparticles
Lee, G. H., Lee, S. J., Jeong, S. W., Kim, H.-C., Park, G. Y., Lee, S. G., & Choi, J. H. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.060 · Cited by 94
Szymańska, E., Orłowski, P., Winnicka, K., Tomaszewska, E., Bąska, P., Celichowski, G., Grobelny, J., Basa, A., & Krzyżowska, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020387 · Cited by 92
Du, T., Dong, N., Fang, L., Lu, J. H., Bi, J., Xiao, S., & Han, H. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c00970 · Cited by 91
Mazurków, J., Yüzbasi, N. S., Domagała, K. W., Pfeiffer, S., Kata, D., & Graule, T. J. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b05211 · Cited by 86
Size-dependent inhibition of herpesvirus cellular entry by polyvalent nanoarchitectures
Ziem, B., Azab, W., Gholami, M. F., Rabe, J. P., Osterrieder, N., & Haag, R. (2017) · Nanoscale · doi:10.1039/c7nr00611j · Cited by 85
Bimbo, L. M., Denisova, O. V., Mäkilä, E. M., Kaasalainen, M. H., Brabander, J. K. D., Hirvonen, J. J., Salonen, J., Kakkola, L., Kainov, D. E., & Santos, H. A. (2013) · ACS Nano · doi:10.1021/nn402062f · Cited by 80
Pollock, S., Nichita, N. B., Böhmer, A., Radulescu, C., Dwek, R. A., & Zitzmann, N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009445107 · Cited by 76
Nanoparticle-based artificial RNA silencing machinery for antiviral therapy
Wang, Z., Liu, H., Yang, S. H., Wang, T., Liu, C., & Cao, Y. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207766109 · Cited by 76
Virus-Derived Peptides for Clinical Applications
Yang, M., Sunderland, K. S., & Mao, C. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00100 · Cited by 74
Yin, Y., Xiao-ya, Y., Hu, L., Tan, Z., Zhao, L., Zhang, Z., Liu, J., & Jiang, G. (2016) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6b00066 · Cited by 71
Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus
Surnar, B., Kamran, M. Z., Shah, A. S., Basu, U., Kolishetti, N., Deo, S. K., Jayaweera, D. T., Daunert, S., & Dhar, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b02807 · Cited by 70
Pan, H., Zhang, P., Gao, D., Zhang, Y., Li, P., Liu, L., Wang, C., Wang, H., Ma, Y., & Cai, L. (2014) · ACS Nano · doi:10.1021/nn501028b · Cited by 69
Encapsulating Quantum Dots into Enveloped Virus in Living Cells for Tracking Virus Infection
Zhang, Y., Ke, X., Zheng, Z., Zhang, C., Zhang, Z., Zhang, F., Hu, Q., He, Z., & Wang, H. (2013) · ACS Nano · doi:10.1021/nn305189n · Cited by 69
Russo, E., Gaglianone, N., Baldassari, S., Parodi, B., Cafaggi, S., Zibana, C., Donalisio, M., Cagno, V., Lembo, D., & Caviglioli, G. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.037 · Cited by 66
Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies
Oswald, M., Geißler, S., & Göpferich, A. M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00158 · Cited by 66
Bioinspired Artificial Nanodecoys for Hepatitis B Virus
Liu, X., Yuan, L., Zhang, L., Mu, Y., Li, X., Liu, C., Lv, P., Zhang, Y., Cheng, T., Yuan, Q., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807212 · Cited by 63
Wen, W., Lin, M., Su, C., Wang, S., Cheng, Y. E., Fang, J., & Wong, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900515g · Cited by 56
Microbial Biosynthesis of Silver Nanoparticles in Different Culture Media
Luo, K., Jung, S., Park, K.-H., & Kim, Y. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05092 · Cited by 56
Haimov, E., Weitman, H., Polani, S., Schori, H., Zitoun, D. O., & Shefi, O. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16455 · Cited by 55
Survival of Adenovirus Types 2 and 41 in Surface and Ground Waters Measured by a Plaque Assay
Rigotto, C., Hanley, K. W., Rochelle, P. A., et al. (2011) · Environmental Science & Technology · doi:10.1021/es103922r · Cited by 53
Labeling the nucleocapsid of enveloped baculovirus with quantum dots for single-virus tracking
Wen, L., Lin, Y., Zheng, Z., Zhang, Z., Zhang, L., Wang, L., Wang, H., & Pang, D. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.069 · Cited by 50
Liu, H., Bai, Y., Zhou, Y., Feng, C., Liu, L., Fang, L., Liang, J., & Xiao, S. (2017) · RSC Advances · doi:10.1039/c7ra03167j · Cited by 50
Self-citationSepúlveda‐Crespo, D., Sánchez-Rodríguez, J., Serramía, M. J., Gómez, R., de la Mata, F. J., Jiménez, J. L., & Muñoz‐Fernández, M. Á. (2015) · Nanomedicine · doi:10.2217/nnm.14.79 · Cited by 49
Lee, E. C., Davis-Poynter, N. J., Nguyen, C. T. H., Peters, A. A., Monteith, G. R., Strounina, E. V., Popat, A., & Ross, B. P. (2016) · Nanoscale · doi:10.1039/c6nr03878f · Cited by 49
Huo, C., Xiao, J. Z., Xiao, K., Zou, S., Wang, M., Qi, P., Liu, T., & Hu, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s221667 · Cited by 49
Engineering of the Bacillus circulans β-Galactosidase Product Specificity
Yin, H., Pijning, T., Meng, X., Dijkhuizen, L., & van Leeuwen, S. S. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00032 · Cited by 48
Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization, and Antiviral Activity
González, C. E. P., García‐Broncano, P., Ottaviani, M. F., Cangiotti, M., Fattori, A., Hierro‐Oliva, M., González-Martín, M. L., Pérez‐Serrano, J., Gómez, R., Muñoz‐Fernández, M. Á., et al. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201504262 · Cited by 47
Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections
Colpitts, C. C., Verrier, E. R., & Baumert, T. F. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00039 · Cited by 47
Hepatitis C virus management: potential impact of nanotechnology
Elberry, M. H., Darwish, N. H. E., & Mousa, S. A. (2017) · Virology Journal · doi:10.1186/s12985-017-0753-1 · Cited by 42
Alonas, E. J., Lifland, A. W., Gudheti, M. V., Vanover, D. A., Jung, J., Zurla, C., Kirschman, J. L., Fiore, V. F., Douglas, A. M., Barker, T. H., et al. (2013) · ACS Nano · doi:10.1021/nn405998v · Cited by 39
Luo, R., Fang, L., Jin, H., Wang, D., An, K., Xu, N., Chen, H., & Xiao, S. (2014) · Journal of Proteome Research · doi:10.1021/pr400852d · Cited by 37
Aniagyei, S. E., Sims, L. B., Malik, D. A., Tyo, K. M., Curry, K. C., Kim, W., Hodge, D. A., Duan, J., & Steinbach-Rankins, J. M. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.029 · Cited by 36
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors
Capuzzi, S. J., Sun, W., Muratov, E. N., Martínez-Romero, C., He, S., Zhu, W., Li, H., Tawa, G., Fisher, E. G., Xu, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00035 · Cited by 35
Antiviral therapy of hepatitis delta virus infection — progress and challenges towards cure
Wranke, A., & Wedemeyer, H. H. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.10.002 · Cited by 33
Gelatin modified lipid nanoparticles for anti- viral drug delivery
Joshy, K. S., Snigdha, S., Kalarikkal, N., Pothen, L. A., & Thomas, S. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.07.002 · Cited by 33
Interactions of Fullerene‐Polyglycerol Sulfates at Viral and Cellular Interfaces
Donskyi, I. S., Drüke, M., Silberreis, K., Lauster, D. C., Ludwig, K., Kühne, C., Unger, W. E. S., Böttcher, C., Herrmann, A., Dernedde, J., et al. (2018) · Small · doi:10.1002/smll.201800189 · Cited by 33
Ortega-Berlanga, B., Hernández‐Adame, L., del Angel-Olarte, C., Aguilar, F., Rosales‐Mendoza, S., & Palestino, G. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123414 · Cited by 31
Probing the interactions of CdTe quantum dots with pseudorabies virus
Du, T., Cai, K., Han, H., Fang, L., Liang, J., & Xiao, S. (2015) · Scientific Reports · doi:10.1038/srep16403 · Cited by 30
Self-citationPathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes
Rivera, A., & Messaoudi, I. (2015) · ACS Infectious Diseases · doi:10.1021/id5000426 · Cited by 28
Lancelot, A., Claveria‐Gimeno, R., Velázquez‐Campoy, A., Abián, O., Serrano, J. L., & Sierra, T. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2017.03.012 · Cited by 28
Kim, S. S., Jyothi, Beloor, J., Jo, A., Nguyen, M. N., Choi, T. G., Kim, J. H., Akter, S., Lee, S.-K., Baik, H. H., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74723 · Cited by 24
Zhou, Y., Bai, Y., Liu, H., Jiang, X., Tong, T., Fang, L., Wang, D., Ke, Q., Liang, J., & Xiao, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b09402 · Cited by 24
Self-citationAiad, I. A., Marzouk, M. I., Shaker, S. A., Ebrahim, N. E., Abd‐Elaal, A. A., & Tawfik, S. M. (2017) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2017.08.072 · Cited by 23
Silver nanoparticles synthesized using Eucommia ulmoides bark and their antibacterial efficacy
Lü, S.-F., Wu, Y., & Liu, H. (2017) · Materials Letters · doi:10.1016/j.matlet.2017.03.068 · Cited by 22
Nanotherapeutic Anti-influenza Solutions: Current Knowledge and Future Challenges
Enkhtaivan, G., Anthonydhason, V., Jung, S., Kim, D. H., Muthu, M., Gopal, J., & Chun, S. (2018) · Journal of Cluster Science · doi:10.1007/s10876-018-1417-z · Cited by 11
Reprogramming the Activatable Peptide Display Function of Adeno-Associated Virus Nanoparticles
Thadani, N. N., Dempsey, C., Zhao, J. X., Vasquez, S. M., & Suh, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b07804 · Cited by 9
Candidate Medical Countermeasures Targeting Ebola Virus Cell Entry
Liang, J. Y., Jangra, R. K., Bollinger, L., Wada, J., Radoshitzky, S. R., Chandran, K., Jahrling, P. B., Kuhn, J. H., & Jensen, K. S. (2017) · Future Virology · doi:10.2217/fvl-2016-0113 · Cited by 2
Self-citation
Cited by
Carbon Dots in Bioimaging, Biosensing and Therapeutics: A Comprehensive Review
Wang, B., Cai, H., Waterhouse, G. I. N., Qu, X., Yang, B., & Lu, S. (2022) · Small Science · doi:10.1002/smsc.202200012 · Cited by 411
Plant Extracts Mediated Metal-Based Nanoparticles: Synthesis and Biological Applications
Adeyemi, J. O., Oriola, A. O., Onwudiwe, D. C., & Oyedeji, A. O. (2022) · Biomolecules · doi:10.3390/biom12050627 · Cited by 367
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 348
Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 295
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
Metadata
- Authors
- Chen, L., & Liang, J.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 112
- Pages
- 110924
- ISSN
- 0928-4931 (ISSN-L)
- OpenAlex
- W3015494993
- Cited by
- 255
- References
- 92
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.